AURIGENE.AI Trademark

Recorded and downloadable computer software specifically designed for drug discovery and pharmaceutical drug development using artificial intelligence; Recorded and downloadable computer software specifically designed for in-vitro experimental testing and diagnostics, in-vivo experimental testing and diagnostics, biomedical diagnosis, molecular structure search, intelligent and novel molecule design, compound library screening, new chemical design prediction, aids in early identification of potential failures, for analyzing and developing predictive AI models and generative AI models, for developing, deploying and optimizing computational models, and for computer-aided drug design, for AI-enabled molecular docking and structure-based virtual screenings with computer-aided drug design (CADD) models; recorded and downloadable computer software specifically designed for using predictive and generative AI to develop data science models and for scientific research; recorded and downloadable computer software specifically designed for using predictive and generative AI models and computer-aided drug design (CADD) models to predict how a compound would bind to a target protein; recorded and downloadable computer software specifically designed for using predictive and generative AI models for virtual screening of enumerated target-focused molecules, designing molecules and new chemicals, physics-based and physics-level simulations including molecular dynamics simulations using computational models; recorded and downloadable computer software specifically designed for using predictive and generative AI models to analyze chemical compounds and predict which ones are likely to bind to a disease target; recorded and downloadable computer software specifically designed for using predictive and generative AI models to simulate how a drug moves, bends, and interacts with a target on an atomic level; recorded and downloadable computer software specifically designed for using predictive and generative AI models and computer-aided drug design (CADD) models to predict how a compound would bind to a target protein; all of the foregoing for drug discovery and pharmaceutical drug development using artificial intelligence